Safety and Effectiveness of H5N1 Influenza Vaccine from Silkworms
Author Information
Author(s): Jin Rongzhong, Lv Zhengbing, Chen Qin, Quan Yanping, Zhang Haihua, Li Si, Chen Guogang, Zheng Qingliang, Jin Lairong, Wu Xiangfu, Chen Jianguo, Zhang Yaozhou
Primary Institution: Zhejiang University, Hangzhou, China
Hypothesis
Can a recombinant H5N1 influenza vaccine based on a baculovirus system be safe and effective in inducing immunity in monkeys?
Conclusion
The vaccine induced neutralizing antibodies and showed no toxicity, suggesting it may be a safe and effective candidate for human use.
Supporting Evidence
- The vaccine induced neutralizing antibodies in 50% to 67% of monkeys at different doses.
- No toxicity was observed at doses up to 3.2 mg/kg in cynomolgus monkeys.
- The HA protein constituted approximately 3% of the total viral proteins in infected silkworms.
Takeaway
Scientists created a new flu vaccine using silkworms, and it worked well in monkeys without making them sick.
Methodology
The study involved immunizing rhesus monkeys with different doses of the vaccine and measuring antibody responses and safety.
Limitations
The study was conducted in monkeys, and results may not directly translate to humans.
Participant Demographics
20 rhesus monkeys, 10 males and 10 females, aged 3 to 4 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website